home





























 


















 






















hrsa

participating institutions:
Johns Hopkins University AIDS Service, New York State DOH AIDS Institute, The CORE Center, Cook County Hospital



NEWS AND NEW DEVELOPMENTS:
JUNE 2000





Refractory Mucosal Candidiasis in Advanced HIV Infection [CJ Fichtenbaum, et al. CID 2000;30:749]
posted 6/29/2000

Use of Rifabutin with Protease Inhibitors for HIV-Infected Patients with Tuberculosis [M Narita, et al. CID 2000;30:779]
posted 6/29/2000

Prevalence of and Risks for Cervical Human Papillomavirus Infection and Squamous Intraepithelial Lesions in Adolescent Girls: Impact of Infection with HIV [A-B Moscicki, et al. Arch Ped Adolescent Med 2000;154:127]
posted 6/29/2000

AndroGel - A New Gel Formulation of Testosterone for Transdermal Application - Reviewed by The Medical Letter [Medical Letter 2000;42:49]
posted 6/29/2000

Combination Therapy with Amprenavir, Abacavir, and Efavirenz in HIV-Infected Patients Failing a Protease-Inhibitor Regimen: Pharmacokinetic Drug Interactions and Antiviral Activity[J Falloom, et al. CID 2000;30:313]
posted 6/29/2000

Cost-Effectiveness of Screening for Anal Squamous Intraepithelial Lesions and Anal Cancer in HIV-Negative Homosexual and Bisexual Men[SJ Goldie, et al. Am J Med 2000;108:634]
posted 6/29/2000

Timing the Ancestor of the HIV-1 Pandemic Strains[B Korber, et al. Science 2000;288:1789]
posted 6/29/2000

Discontinuation of Primary Prophylaxis for Pneumocystis Carinii Pneumonia and Toxoplasmic Encephalitis in Human Immunodeficiency Virus Type I-Infected Patients: The Changes in Opportunistic Prophylaxis Study [C Mussini, et al. J Infect Dis 2000; 181: 1635]
posted 6/16/2000

The Effects of Protease Inhibitor Therapy on Human Immunodeficiency Virus Type 1 Levels in Semen (AIDS Clinical Trials Group Protocol 850) [JJ Eron, et al. J Infect Dis 2000; 181: 1622]
posted 6/16/2000

Antiretroviral Agents at Slashed Prices for South Africa [Lancet 2000;355:1799]
posted 6/9/2000

Viral Load Self-Test Kits for HIV-Infected Patients [AIDS Alert, June 2000: 72]
posted 6/9/2000

Incidence of Adverse Reactions in HIV Patients Treated with Protease Inhibitors: A Cohort Study [P Bonfanti, et al. JAIDS 2000;23:236]
posted 6/6/2000

St. John's Wort Included in U.S. Depression Guidelines [Lancet 2000;355:1619]
posted 6/6/2000

Serum Triglycerides, HIV Infection, and Highly Active Antiretroviral Therapy, Aquitaine Cohort, France, 1996 to 1998 [R Thiebaut, et al. JAIDS 2000; 23: 261]
posted 6/6/2000

A Double-blind, Placebo-Controlled Trial of Testosterone Therapy for HIV-Positive Men with Hypogonadal Symptoms [JG Rabkin, et al. Arch Gen Psych 2000;57:141]
posted 6/6/2000

HIV/AIDS: The Peril of Pseudoscience [MW Makgoba, Science post2000;288:1171]
posted 6/6/2000

South Africa Turns to Research in the Hope of Settling AIDS Policy [Nature 2000;405:105]
posted 6/6/2000

Combination Therapies for HIV and Sexual Risk Behavior Among Gay Men [J Elford, et al. JAIDS 2000;23:266]
posted 6/6/2000

Pharmacokinetic Interaction of Abacavir and Ethanol in HIV-Infected Adults [JA McDowell, et al. AAC 2000;44:1686]
posted 6/6/2000

Update on Microbicides [J Stephenson. JAMA 2000;283:1811]
posted 6/6/2000




Copyright © 2001-2002. The National AIDS Education and Training Centers Program on behalf of its AETC National Resource Center. All rights reserved.

Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained in this site because no single reference or service can take the place of medical training, education, and experience. Consumers are cautioned that this site is not intended to provide medical advice about any specific medical condition they may have or treatment they may need, and they are encouraged to call or see their physician or other health care provider promptly with any health related questions they may have.